AstraZeneca Sues Generics Maker Over Nexium Patents
The generics maker filed an abbreviated new drug application for time-released esomeprazole magnesium tablets with the U.S. Food and Drug Administration in December, claiming the unexpired Nexium patents are unenforceable or won't be infringed by the generic treatment with the same active ingredient.
AstraZeneca asks in the complaint that approval of Torrent's drug...
Already a subscriber? Click here to login